BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 25377915)

  • 1. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
    Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
    Kim J; Imig JD; Yang J; Hammock BD; Padanilam BJ
    Am J Physiol Renal Physiol; 2014 Oct; 307(8):F971-80. PubMed ID: 25164080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis.
    Stavniichuk A; Hye Khan MA; Yeboah MM; Chesnik MA; Jankiewicz WK; Hartmann M; Blöcher R; Kircher T; Savchuk O; Proschak E; Imig JD
    Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106472. PubMed ID: 32569747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
    Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
    Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
    J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
    Sanders WG; Morisseau C; Hammock BD; Cheung AK; Terry CM
    Am J Physiol Cell Physiol; 2012 Aug; 303(3):C278-90. PubMed ID: 22621785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Zhang CH; Zheng L; Gui L; Lin JY; Zhu YM; Deng WS; Luo M
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):118-125. PubMed ID: 29031875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.
    Chiang CW; Lee HT; Tarng DC; Kuo KL; Cheng LC; Lee TS
    Mediators Inflamm; 2015; 2015():693260. PubMed ID: 25688176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?
    Devocelle A; Lecru L; Ferlicot S; Bessede T; Candelier JJ; Giron-Michel J; François H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy.
    Wang Q; Liang Y; Qiao Y; Zhao X; Yang Y; Yang S; Li B; Zhao Q; Dong L; Quan S; Tian R; Liu Z
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F915-F926. PubMed ID: 29717935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy.
    Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y
    Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
    Liao J; Hwang SH; Li H; Yang Y; Yang J; Wecksler AT; Liu JY; Hammock BD; Yang GY
    Cancer Lett; 2016 Feb; 371(2):187-93. PubMed ID: 26683769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
    Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KS370G, a caffeamide derivative, attenuates unilateral ureteral obstruction-induced renal fibrosis by the reduction of inflammation and oxidative stress in mice.
    Chuang ST; Kuo YH; Su MJ
    Eur J Pharmacol; 2015 Mar; 750():1-7. PubMed ID: 25620133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.